CAR T-Cell Therapy
Home / CAR T-Cell Therapy
CAR T-Cell Therapy
CAR T is a personalised immunotherapy. We collect your T‑cells, engineer them with a chimeric antigen receptor (CAR) to recognise cancer, grow millions of these cells, and infuse them back to fight the disease. Currently used in blood cancers like leukaemia and lymphoma; future expansions planned.
- Process: Consultation → Apheresis → Cell Engineering → Conditioning → Infusion → Monitoring
- Typical timeline: 2–4 weeks; clinical suitability assessed individually.